Urologix Total Debt vs. Retained Earnings

ULGXDelisted Stock  USD 0.0001  0.00  0.00%   
Based on the key profitability measurements obtained from Urologix's financial statements, Urologix may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Urologix's ability to earn profits and add value for shareholders.
For Urologix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Urologix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Urologix utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Urologix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Urologix over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please note, there is a significant difference between Urologix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Urologix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Urologix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Urologix Retained Earnings vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Urologix's current stock value. Our valuation model uses many indicators to compare Urologix value to that of its competitors to determine the firm's financial worth.
Urologix is rated third in total debt category among its peers. It is rated fourth in retained earnings category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Urologix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Urologix's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Urologix Total Debt vs. Competition

Urologix is rated third in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 36.49 Million. Urologix retains roughly 4.59 Million in total debt claiming about 13% of equities under Health Care industry.
Total debt  Revenue  Capitalization  Workforce  Valuation

Urologix Retained Earnings vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Urologix

Total Debt

 = 

Bonds

+

Notes

 = 
4.59 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Urologix

Retained Earnings

 = 

Beginning RE + Income

-

Dividends

 = 
(126.63 M)
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.

Urologix Retained Earnings Comparison

Urologix is currently under evaluation in retained earnings category among its peers.

Urologix Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Urologix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Urologix will eventually generate negative long term returns. The profitability progress is the general direction of Urologix's change in net profit over the period of time. It can combine multiple indicators of Urologix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia in the United States. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota. UROLOGIX operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 61 people.

Urologix Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Urologix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Urologix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Urologix's important profitability drivers and their relationship over time.

Use Urologix in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Urologix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Urologix will appreciate offsetting losses from the drop in the long position's value.

Urologix Pair Trading

Urologix Pair Trading Analysis

The ability to find closely correlated positions to Urologix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Urologix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Urologix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Urologix to buy it.
The correlation of Urologix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Urologix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Urologix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Urologix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Urologix position

In addition to having Urologix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks
Soft Drinks Theme
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Urologix Pink Sheet

If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges